{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:52:21Z","timestamp":1760647941425,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jns.2024.122935","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:29:18Z","timestamp":1707974958000},"page":"122935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High brain natriuretic peptide level is associated with severe stroke in patients taking oral anticoagulants: A sub-analysis of the PASTA registry study"],"prefix":"10.1016","volume":"458","author":[{"given":"Satoshi","family":"Suda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.122935_bb0005","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure","volume":"128","author":"Roger","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.jns.2024.122935_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"issue":"2016","key":"10.1016\/j.jns.2024.122935_bb0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jns.2024.122935_bb0020","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1253\/circj.CJ-17-1085","article-title":"Impact of B-type natriuretic peptide level on risk stratification of thromboembolism and death in patients with nonvalvular atrial fibrillation - the Hokuriku-Plus AF registry","volume":"82","author":"Hayashi","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2024.122935_bb0025","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.jns.2024.122935_bb0030","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","article-title":"N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE trial (Apixaban for the prevention of stroke in subjects with atrial fibrillation)","volume":"61","author":"Hijazi","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2024.122935_bb0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamacardio.2016.3311","article-title":"Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: a subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"1","author":"Ruff","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jns.2024.122935_bb0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/heartjnl-2020-317735","article-title":"Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure","volume":"107","author":"Hamatani","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jns.2024.122935_bb0045","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/STROKEAHA.114.008311","article-title":"B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis","volume":"46","author":"Llombart","year":"2015","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2024.122935_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000457808","article-title":"Brain natriuretic peptide is a powerful predictor of outcome in stroke patients with atrial fibrillation","volume":"7","author":"Maruyama","year":"2017","journal-title":"Cerebrovasc. Dis. Extra."},{"key":"10.1016\/j.jns.2024.122935_bb0055","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2169\/internalmedicine.48.2166","article-title":"Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke","volume":"48","author":"Shibazaki","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2024.122935_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007329","article-title":"Heads and tails of natriuretic peptides: neuroprotective role of brain natriuretic peptide","volume":"6","author":"Fern\u00e1ndez-Susavila","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jns.2024.122935_bb0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.STR.0000151364.19066.a1","article-title":"Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis","volume":"36","author":"Etgen","year":"2005","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2024.122935_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/STROKEAHA.111.629212","article-title":"Brain natriuretic peptide predicts functional outcome in ischemic stroke","volume":"43","author":"Rost","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.122935_bb0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/000331970505600610","article-title":"N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke","volume":"56","author":"Giannakoulas","year":"2005","journal-title":"Angiology."},{"key":"10.1016\/j.jns.2024.122935_bb0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2169\/internalmedicine.8113-21","article-title":"Characteristics of ischemic versus hemorrhagic sStroke in atients receiving oral anticoagulants: results of the PASTA study","volume":"61","author":"Suda","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2024.122935_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104456","article-title":"Multicenter prospective analysis of stroke patients taking oral anticoagulants: the PASTA registry \u2013 study design and characteristics","volume":"28","author":"Suda","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2024.122935_bb0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2169\/internalmedicine.8113-21","article-title":"Characteristics of ischemic versus hemorrhagic stroke in patients receiving oral anticoagulants: results of the PASTA study","volume":"61","author":"Suda","year":"2021","journal-title":"Intern. Med. (Tokyo, Japan)"},{"key":"10.1016\/j.jns.2024.122935_bb0095","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group, JCS 2017\/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2024.122935_bb0100","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00415-017-8646-1","article-title":"Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke","volume":"264","author":"Suda","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.122935_bb0105","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1253\/circj.CJ-18-0561","article-title":"Anticoagulants, reperfusion therapy, and outcomes in ischemic stroke patients with non-valvular atrial fibrillation - a single-center, 6-year experience of 546 consecutive patients","volume":"82","author":"Suda","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2024.122935_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.003","article-title":"Brain natriuretic peptide in acute ischemic stroke","volume":"23","author":"Maruyama","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2024.122935_bb0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000342887","article-title":"Brain natriuretic peptide as a predictor of cardioembolism in acute ischemic stroke patients: brain natriuretic peptide stroke prospective study","volume":"69","author":"Sakai","year":"2013","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2024.122935_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2019.03.031","article-title":"Accurate etiology diagnosis in patients with stroke and atrial fibrillation: a role for brain natriuretic peptide","volume":"400","author":"Sakamoto","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.122935_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.682538","article-title":"A review of biomarkers for ischemic stroke evaluation in patients with non-valvular atrial fibrillation","volume":"8","author":"Shang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jns.2024.122935_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.107021","article-title":"Correlation between the B-type natriuretic peptide before thrombolysis and prognosis in patients with ischemic stroke","volume":"211","author":"Pan","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2024.122935_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7150\/ijms.5005","article-title":"Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volume","volume":"10","author":"Kim","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jns.2024.122935_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1468-1331.2010.03101.x","article-title":"Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation","volume":"18","author":"Shibazaki","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2024.122935_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12947-016-0047-6","article-title":"Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study","volume":"14","author":"Pant","year":"2016","journal-title":"Cardiovasc. Ultrasound"},{"key":"10.1016\/j.jns.2024.122935_bb0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12574-017-0362-4","article-title":"Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function","volume":"16","author":"Harada","year":"2018","journal-title":"J. Echocardiogr."},{"key":"10.1016\/j.jns.2024.122935_bb0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1253\/circj.CJ-16-1089","article-title":"Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy - warfarin vs. direct oral anticoagulants","volume":"81","author":"Kawabata","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.jns.2024.122935_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12603-018-1112-7","article-title":"Association of BNP with frailty in elderly population: Rugao longevity and ageing study","volume":"23","author":"Yao","year":"2019","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.jns.2024.122935_bb0165","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.122935_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.122935_bb0175","doi-asserted-by":"crossref","unstructured":"F.A. Simader, J.P. Howard, Y. Ahmad, K. Saleh, A. Naraen, J.W. Samways, J. Mohal, R.K. Reddy, N. Kaza, D. Keene, M.J. Shun-Shin, D.P. Francis, Z.I. Whinnett, A.D. Arnold, Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials, Europace. 25 (2023) 341\u2013350. doi: 10.1093\/europace\/euac173.","DOI":"10.1093\/europace\/euac173"},{"key":"10.1016\/j.jns.2024.122935_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2023.01.070","article-title":"A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure","volume":"377","author":"Casula","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2024.122935_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M18-0992","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"170","author":"Turagam","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2024.122935_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jns.2019.05.023","article-title":"Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke\/transient ischemic attack patients with non-valvular atrial fibrillation","volume":"402","author":"Tomari","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.122935_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009507","article-title":"Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation","volume":"7","author":"Sakamoto","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jns.2024.122935_bb0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000381218","article-title":"Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke","volume":"22","author":"Bunevicius","year":"2015","journal-title":"Neuroimmunomodulation."},{"key":"10.1016\/j.jns.2024.122935_bb0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2005.03.039","article-title":"Abnormalities on ECG and telemetry predict stroke outcome at 3 months","volume":"234","author":"Christensen","year":"2005","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:06:15Z","timestamp":1758384375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"alternative-id":["S0022510X24000704"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.122935","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High brain natriuretic peptide level is associated with severe stroke in patients taking oral anticoagulants: A sub-analysis of the PASTA registry study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.122935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122935"}}